Besides the conventional digital rectal examination (DRE) and the controversy surrounding prostate specific antigen (PSA)-based screening, ultrasonography (US) and magnetic resonance imaging (MRI) are the most common imaging technologies to screen for prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.